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Introduction: Vitamin D inadequacy or deficiency (VDID) has been reported in a
high percentage of otherwise healthy individuals. Factors that may contribute to
the high prevalence of VDID in people with mental disorders include diet low in
vitamin D, poor sunlight exposure, decrease in cutaneous vitamin D synthesis,
intake of certain medications, poor mobility, excessive alcohol intake, and tobacco
smoking. VDID has been correlated to a host of adverse conditions, including rickets,
osteoporosis, osteomalacia, muscle diseases, depression, cognitive dysfunction, and
even certain cancers.
Objectives: The purpose of this study was to report the prevalence and correlates of
vitamin D inadequacy in a sample of 290 psychiatric patients admitted to inpatient or day
hospital treatment at the University of Siena Medical Center.
Methods: We retrospectively evaluated the prevalence of VDID in 290 psychiatric
inpatients’ medical records during the year 2017 and evaluated the correlates of VDID in
patients with mental illness.
Results: Two hundred and seventy two out of two hundred and ninety patients
(94%) showed VDID. Physical activity and regular diet were positively correlated with
vitamin D levels whereas age, tobacco smoking, PTH, alkaline phosphatase levels were
negatively correlated. Statistically significant differences were found among smokers and
non-smokers in all study groups.
Conclusions: VDID was highly prevalent in our sample. In addition to vitamin D
supplementation, psychosocial intervention able to promote and help sustain physical
activity, appropriate diet, quitting smoking and sensible sun exposure to prevent and
treat VDID in patients with mental health should be implemented, tested, and introduced
in our clinical practice.
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INTRODUCTION
Vitamin D (vit D), also known as sunshine vitamin is an essential
component for a number of physiological functions such as
muscle performance, bone metabolism, calcium and phosphorus
omeosthasis and immunity. Vit D may be produced via sun
exposure or obtained from food (1). According to Clinical
Practice Guidelines from the US Endocrine Society, vitamin D
deficiency is defined as serum 25-OH D <50 nmol/l (below
20 ng/ml). Vit D insufficiency is defined as serum levels of 25-
OH D ranging between 50 and 75 nmol/l (21–29 ng/ml) (2, 3).
Vit D deficiency is a global health issue affecting individuals of
all ages (4). There are number of factors causing deficiency, with
lack of sunlight exposure and poor dietary intake being the most
important (5). The mean prevalence of Vit D deficiency in US
population has been reported to be 37.5% (6). It is associated with
various metabolic, neoplastic and immunological disorders such
as atherosclerosis, diabetes mellitus and colon cancer (2, 7).
Vit D also plays an important role in mental health and
cognitive functions (8, 9). Vit D receptors are present in
various parts of the brain, including the amygdala, which is
associated with the regulation of emotions and behavior (10).
Vit D regulates intra and extracellular calcium concentration in
neurons (11). Researchers found that patients with low vitamin
D levels suffer from mood disorders (12, 13). In addition,
vit D deficiency has been associated with neuropsychiatric
conditions such as Parkinson’s disease, schizophreniform
disorder, multiple sclerosis (MS), Alzheimer’s disease and autism
spectrum disorders (14–16). Other studies have found significant
relationships between deficiency of vitamin D and depressive
symptoms or cognitive impairment (17, 18).
The main reasons for vitamin D deficiency in patients with
psychiatric disease are low exposure to sunlight and poor diet
(19). Anticonvulsant therapy may play a role as well (20).
Although it is not a common practice to screen psychiatric
patients for vitamin D deficiency, evidence suggests that vit D
levels should be included in routine screening. For example,
a study conducted in UK found that 100% psychiatric male
inpatients were vitamin D deficient during hospital treatment
(21). In another study conducted in the same country, researchers
found that 83% of hospitalized inpatients were Vitamin D
deficient (22).
The purpose of the study was to report the prevalence and
correlates of vit D deficiency in a sample of 290 psychiatric
patients admitted to inpatient or day hospital treatment at the
University of Siena Medical Center.
METHODS
We retrospectively evaluated the medical records of 290 patients
admitted to inpatient or day hospital treatment from January to
December 2017.
The following information was extracted from the clinical
charts: socio-demographic variables (age, sex, date, and place
of birth); main psychiatric diagnosis; vitamin D serum levels
and other parameters of the phosphocalcic metabolism (PTH,
alkaline phosphatase, calcium, magnesium, and phosphorus);
prolactin serum levels; body weight, height and body mass index
(BMI); regular diet (as expressed by at least two meals per
day); regular physical activity (as expressed by aerobic activity
>20min at least 2 days per week); smoking tobacco; medical
comorbidities. All data above was collected retrospectively and
no examwas specifically conducted for the purposes of this study.
For the reasons above, the study was exempt from informed
consent. The study was approved by the Regione Toscana - Area
Vasta SudEst Ethical Committee Board.
We excluded confounding conditions that may contribute to
low vitamin D levels such as malnutrition (eating disorders
and/or wasting syndrome due to medical reasons) or
malabsorption (celiac disease, inflammatory bowel disease,
exocrine pancreatic insufficiency from cystic fibrosis and/or
short bowel syndrome). Subjects with metabolic bone diseases
(such as osteoporosis, rickets, osteomalacia, osteopetrosis,
Paget disease of bone, and fibrous dysplasia) and pathological
hyperprolactinemia not drug induced (such as pituitary micro-
and macroadenomas, prolactinoma, chronic renal failure, and
patients on hemodialysis) were also excluded.
Descriptive statistics were used to summarize the participant
characteristics. Participants were then divided into three groups
based on their vit d Levels: (1) vit D deficiency (vit D
levels <10 ng/ml); (2) vit D insufficiency (vit D levels =
10–29.99 ng/ml); (3) vit D adequacy (vit D levels greater
≥30 ng/ml). The three groups were compared with chi-square
tests on categorical variables such as gender, physical activity,
smoke, diagnosis (bipolar disorder vs. other disorders), season
(other seasons vs. summer) and drug treatment, and with
Kruskal-Wallis test on quantitative variables (age, BMI, PRL,
Magnesium, Calcium, Phosphorus, Alkaline phosphatase, and
PTH) because they showed a non-normal distribution, as
assessed using Shapiro-Wilks test. The significance level was
set at p < 0.05. Variables that differed significantly among the
three groups of vitamin D levels were entered as independent
variables in a logistic regression model with a forward stepwise
procedure. In this model, vitamin D was used a dependent
variable, coded as deficiency vs. no deficiency. Statistical analyses
were performed using SPSS for Windows version 22.0 and
PRISM GraphPad.
RESULTS
The sample consisted of 290 patients, of which 127 were males
(43.8%) and 163 females (56.2%). The mean age was 47.8 years.
The majority of patients had a diagnosis of mood disorders
(n = 251, 86.6%): among these 243 (83.8%) had a diagnosis
of bipolar disorder and 8 (2.8%) of major depressive disorder;
other diagnoses were schizophrenia or psychosis (n = 8; 2.8%),
post-traumatic stress disorder (n = 17; 5.9%), other mental
disorders (anxiety disorders, neurodevelopmental disorder) (n=
14; 4.8). The mean values for the anthropometric parameters of
the sample were: weight 75 kg, height 169 centimeters, BMI 26.2
kg/m2. About three quarters of patients (219/75.5%) followed a
regular diet, 147 (50.7%) were smokers, and 75 (25.9%) reported
to practice regular physical activity.
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TABLE 1 | Demographic and clinical characteristics of study participants according to vit D levels.
Variables Deficiency <10 ng/ml Insufficiency 10–30 ng/ml Adequacy ≥30 ng/ml P-value
N 89 183 18 –
Males, n (%) 39 (43.8) 82 (44.8) 6 (33.3) χ2 = 0.87677, df = 2, p = 0.645
Physical activity, n (%) 10 (11.2) 49 (26.8) 16 (88.9) FET, p < 0.0001
Smoke, n (%) 68 (76.4) 79 (43.2) 0 (0.0) χ2 = 46.189, df = 2, p ≤ 0.0001
Age (Median) 54.4 45.2 48.1 KW = 13.284, df = 2, p < 0.01
BMI (Median) 26.2 26.1 26.9 KW = 0.295, df = 2, p = 0.863
Drug treatment, n (%) 81 (91.0) 161 (88.0) 15 (83.3) FET, p = 0.524
PRL (Median) 275.3 272.5 318.2 KW = 0.1223, df = 2, p = 0.941
Magnesium (Median) 2.1 2.0 2.1 KW = 3.476, df = 2, p = 0.176
Calcium (Median) 9.4 9.5 9.5 KW = 1.3197 df = 2, p = 0.517
Phosphorus (Median) 3.2 3.2 3.3 KW = 0.47053, df = 2, p = 0.790
Alkaline phosphatase (Median) 68 59 61 KW = 12.585, df = 2, p < 0.01
PTH (Median) 37.0 28.0 25.5 KW = 18.558, df = 2, p < 0.0001
BMI, Body Mass Index; df, degrees of freedom; FET, Fisher Exact Test; KW, Kruskal-Wallis; N, Number; ng/mL, Nanograms Per Milliliter; PRL, Prolactin; PTH, parathyroid hormone;
χ
2, chi-square. Bold values statistically significant.
Ninety-four percent (n = 272) of the 290 study subjects
showed vit D levels below the normal range (vit D ≥30 ng/ml).
Specifically, 31% met criteria for vit D deficiency (vit D levels
<10 ng/ml), and 63% had vit D insufficiency (vit D levels
= 10−30 ng/ml). The mean vitamin D levels was 15.3 ng/ml
(±7.7 ng/ml). Not surprisingly, vit D levels were higher in
samples collected in the months of July and August. Vit D levels
were inversely proportional to age (p < 0.001). No significant
relationship between vitamin D levels and gender was found
(p = 0.481). Physical activity (p < 0.001) and regular diet (p
< 0.01) were found to be positively and significantly related to
vitamin D levels. Tobacco smoking had a negative association
with vitamin D levels (p < 0.001). No statistically significant
correlations were found between vitamin D levels and calcium,
magnesium, phosphorus and prolactin. However, PTH (p <
0.001) and alkaline phosphatase (p < 0.001) were inversely and
significantly related to vitamin D levels. Psychiatric medications
were unrelated with vitamin D levels (p = 0.935). Demographic
and clinical features of the study sample divided in three groups
based on vitamin D levels (deficiency: <10 ng/ml; insufficiency:
10–30 ng/ml; adequacy: ≥30 ng/ml) are presented in Table 1.
In the multiple logistic regression model, smoking was the
strongest predictor of vit D deficiency (OR = 5.033, 95% CI
2.684–9.435) after adjusting for the effect of season. Older age
and higher PTH values were also significantly associated with an
increased likelihood of vit D deficiency, while physical activity
was associated with a lower likelihood of vit D deficiency (the
p-value was borderline significant, p= 0.053).
DISCUSSION
We found a very high prevalence of VDID, with only 18 (6%)
out of 290 patients with mental illness (mostly bipolar disorder)
showing adequate levels of vitamin D. Our results are in line with
similar studies (20, 21) and indicate that VDID is much greater in
patients with mental illness than in the general population (6). A
recent study evaluated vitamin D serum levels in a representative
sample of 55,844 European individuals, and found that 13.0% had
serum vit D concentrations of less 30 nmol/L (23). The authors
concluded that these rates are concerning and call for action from
a public health perspective.
Our findings highlight a much higher degree of concern
in individuals with mental illness and point to the need of
routinely screening for vitamin D deficiency, as a part of the
standard assessment of patients with mental illness. However,
given that almost all patients resulted deficient in vitamin D,
the possibility to offer vitamin D supplementation to every
patient with mental illness could be considered, as a cost-effective
alternative to general screening. In addition to other benefits, vit
D supplementation may improve the outcomes of illnesses like
depression (24).
It is well-known that the main factors behind vitamin D
deficiencies include the lack of sunlight exposure, poor dietary
intake, smoking, and lack of physical exercise (5). Several studies
have shown that a high number of patients with bipolar illness
smoke tobacco, run a sedentary lifestyle, and have unhealthy
dietary habits (25–28), similarly to what has been described in
patients suffering from schizophrenia (27). Consistently with
other studies in non-psychiatric patients [for instance; (29)],
smokers were more likely to show VDID than non-smokers,
despite the fact that outdoor smoking likely increased the sun
light exposure. Of interest, in the multiple logistic regression
model, smoking was the strongest predictor of vit D deficiency.
This may be due to the fact that the negative influence of smoking
on vitamin D levels is higher than the positive influence of a
few minutes of sun exposure wen people smoke outdoors. Also,
this could be due to the fact that our patients smoked primarily
indoor. In fact, in our inpatient unit, people are allowed to
smoke in a designated smoking area consisting of a fenced and
shaded balcony, with no direct sunlight exposure. It is likely
that our patients smoked indoors before being admitted as well,
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given that a comprehensive smoking ban (e.g., no smoking
policies in apartment buildings) is not widely adopted/enforced
in Italy. Although we did not find a significant relationship
between VDID and specific medications, we cannot rule out
this possibility, because polytherapy was common. For instance,
the effect of antiepileptic drugs on vitamin D levels has been
widely demonstrated.
Our study has several other limitations, including the
retrospective design of the study, the evaluation of vit D levels
via blood samples collected in different seasons of the year, and
the heterogeneity of the sample in terms of psychiatric diagnosis
and socio-demographic features.
CONCLUSIONS
VDID is highly prevalent in patients with mental illness and
is significantly influenced by lifestyle factors, such as diet,
physical inactivity and tobacco smoking (this last with a strong
and negative influence). As we already demonstrated (29)
for other conditions affecting patients with mood disorders,
the development and testing of standardized psychosocial
healthy lifestyle interventions is warranted, as a key tool
to promote and sustain physical and mental well-being of
our patients.
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